Tuesday, August 6, 2019

Granules India#39;s arm gets USFDA nod for Amphetamine Sulfate tablets

Granules India#39;s arm gets USFDA nod for Amphetamine Sulfate tablets The US Food Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by company#39;s subsidiary, Granules Pharmaceuticals Inc, for Amphetamine Sulfate tablets USP 5 mg and 10 mg, Granules India said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2YxEs5a

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...